182 USD
+7.55 (+4.33%)
183.1 USD
+1.1 (+0.6%)
We assign a fundamental rating of 5 out of 10 to ALAB. ALAB was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While ALAB has a great health rating, its profitability is only average at the moment. ALAB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ALAB was profitable.
- In the past year ALAB had a positive cash flow from operations.
1.2 Ratios
- ALAB has a Return On Assets of 14.19%. This is amongst the best in the industry. ALAB outperforms 87.61% of its industry peers.
- ALAB has a Return On Equity of 15.64%. This is in the better half of the industry: ALAB outperforms 79.65% of its industry peers.
- With a decent Return On Invested Capital value of 6.48%, ALAB is doing good in the industry, outperforming 71.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 15.64% | ||
| ROIC | 6.48% |
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALAB has a better Profit Margin (27.50%) than 84.07% of its industry peers.
- ALAB has a Operating Margin of 14.74%. This is in the better half of the industry: ALAB outperforms 72.57% of its industry peers.
- ALAB's Gross Margin of 75.41% is amongst the best of the industry. ALAB outperforms 94.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.74% | ||
| PM (TTM) | 27.5% | ||
| GM | 75.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAB is destroying value.
- Compared to 1 year ago, ALAB has more shares outstanding
- ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- ALAB has an Altman-Z score of 144.23. This indicates that ALAB is financially healthy and has little risk of bankruptcy at the moment.
- ALAB has a better Altman-Z score (144.23) than 100.00% of its industry peers.
- ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 144.23 |
ROIC/WACC0.6
WACC10.81%
2.3 Liquidity
- A Current Ratio of 12.78 indicates that ALAB has no problem at all paying its short term obligations.
- ALAB has a better Current ratio (12.78) than 96.46% of its industry peers.
- A Quick Ratio of 12.27 indicates that ALAB has no problem at all paying its short term obligations.
- The Quick ratio of ALAB (12.27) is better than 97.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.78 | ||
| Quick Ratio | 12.27 |
3. Growth
3.1 Past
- The earnings per share for ALAB have decreased strongly by -269.05% in the last year.
- Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 242.24%.
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
3.2 Future
- The Earnings Per Share is expected to grow by 35.05% on average over the next years. This is a very strong growth
- ALAB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.28% yearly.
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 111.66 indicates a quite expensive valuation of ALAB.
- The rest of the industry has a similar Price/Earnings ratio as ALAB.
- ALAB is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 75.87 indicates a quite expensive valuation of ALAB.
- Based on the Price/Forward Earnings ratio, ALAB is valued a bit more expensive than 60.18% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ALAB to the average of the S&P500 Index (24.29), we can say ALAB is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.66 | ||
| Fwd PE | 75.87 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALAB is on the same level as its industry peers.
- ALAB's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 133.98 | ||
| EV/EBITDA | 256.45 |
4.3 Compensation for Growth
- ALAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as ALAB's earnings are expected to grow with 48.21% in the coming years.
PEG (NY)1.38
PEG (5Y)N/A
EPS Next 2Y54.88%
EPS Next 3Y48.21%
5. Dividend
5.1 Amount
- No dividends for ALAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
182
+7.55 (+4.33%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners76.83%
Inst Owner Change0.58%
Ins Owners11.28%
Ins Owner Change-10.29%
Market Cap30.74B
Revenue(TTM)723.04M
Net Income(TTM)198.87M
Analysts80.74
Price Target205.96 (13.16%)
Short Float %8.22%
Short Ratio2.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)23.34%
Max EPS beat(2)33.19%
EPS beat(4)4
Avg EPS beat(4)27.63%
Min EPS beat(4)13.95%
Max EPS beat(4)40.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.25%
Min Revenue beat(2)9.05%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)7.16%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.01%
PT rev (3m)8.51%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)22.15%
EPS NY rev (1m)1.57%
EPS NY rev (3m)12.13%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)15.05%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)7.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.66 | ||
| Fwd PE | 75.87 | ||
| P/S | 42.51 | ||
| P/FCF | 133.98 | ||
| P/OCF | 116.55 | ||
| P/B | 24.17 | ||
| P/tB | 24.17 | ||
| EV/EBITDA | 256.45 |
EPS(TTM)1.63
EY0.9%
EPS(NY)2.4
Fwd EY1.32%
FCF(TTM)1.36
FCFY0.75%
OCF(TTM)1.56
OCFY0.86%
SpS4.28
BVpS7.53
TBVpS7.53
PEG (NY)1.38
PEG (5Y)N/A
Graham Number16.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 15.64% | ||
| ROCE | 8.2% | ||
| ROIC | 6.48% | ||
| ROICexc | 50.8% | ||
| ROICexgc | 50.8% | ||
| OM | 14.74% | ||
| PM (TTM) | 27.5% | ||
| GM | 75.41% | ||
| FCFM | 31.73% |
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 692.01% | ||
| Cap/Sales | 4.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 236.4% | ||
| Profit Quality | 115.38% | ||
| Current Ratio | 12.78 | ||
| Quick Ratio | 12.27 | ||
| Altman-Z | 144.23 |
F-Score8
WACC10.81%
ROIC/WACC0.6
Cap/Depr(3y)573.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%
EBIT growth 1Y-293.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year240.9%
EBIT Next 3Y91.65%
EBIT Next 5Y56.74%
FCF growth 1Y761.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1174.83%
OCF growth 3YN/A
OCF growth 5YN/A
ASTERA LABS INC / ALAB FAQ
Can you provide the ChartMill fundamental rating for ASTERA LABS INC?
ChartMill assigns a fundamental rating of 5 / 10 to ALAB.
Can you provide the valuation status for ASTERA LABS INC?
ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.
How profitable is ASTERA LABS INC (ALAB) stock?
ASTERA LABS INC (ALAB) has a profitability rating of 4 / 10.
Can you provide the financial health for ALAB stock?
The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.